top of page
Search

Kras Kickers at the 2020 National Lung Cancer Round Table 

Updated: Feb 3, 2020

KRas Kickers will be attending the 2020 National Lung Cancer Roundtable to represent the 25% of the lung cancer patients with a Kirsten rat sarcoma (KRAS) mutation. A comprehensive biomarker test should be completed by a doctor to identify cancer mutations.


Three of the four most deadly U.S. cancers (lung, colon and pancreatic) have a KRAS mutation. There are no specific drugs for KRAS cancers, more research is crucial.


KRasKickers.org is a patient driven conduit advocating for treatments, sharing knowledge & clinical trials for KRAS lung cancer patients pleading to Kick Cancers K Ras!!





ree

 
 
Genentech_Logo.png_dark blue text that reads, "Genetech." Gray italicized text that reads, "a member of the Roche Group."
Blue capitalized text on a gray background. Text reads, "Amgen."
Dark blue text on top of sea foam text. Text reads, "Verastem Oncology."
Black capitalized text that reads, "Revolution Medicine."
bottom of page